A May 23 option paper on Economic Security issued by the Senate Finance Committee indicates that tax deductions for the cost of direct-to-consumer advertising are under consideration for elimination. Although this suggestion may seem alarming, for now, nothing is certain, said Coalition for Healthcare Communication Executive Director John Kamp. "As with previous option papers published by the committee, this document carries the disclosure that no particular policy is endorsed by either the Chairman or Ranking Member at this time," Kamp explained. However, this is a dangerous time for any tax expenditure, including the deductibility of drug marketing costs. Read more.